In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pelias AG

Division of Valneva SE
www.pelias.com

Latest From Pelias AG

Deals Shaping the Medical Industry (1/07)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Deals Shaping the Medical Industry (2/06)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Start-Ups in Brief (1/06)

Start-Up showcases these recently launched companies: AestheRx, Pelias, RND Pharmaceuticals and Ziva Bioscience.

Selected Start-Ups (1/06)

In Vivo briefly summarizes the technologies of these recently founded companies: Ardian, CaraMedica, Celerus Diagnostics, GlycoMar, Pelias and Rhythmia Medical.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Austria
  • Parent & Subsidiaries
  • Valneva SE
  • Senior Management
  • Mathias Grote, PhD, CEO
  • Contact Info
  • Pelias AG
    Phone: (43) 1 718 03 26 100
    Dannebergplatz 16/2
    Vienna, 1030
    Austria
UsernamePublicRestriction

Register